DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 7.98% to $1.50 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.87% to 17,449.89 and the Dow Jones Industrial Average falling 0.03% to 41,989.96.
This was the stock's third consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 88.84% short of its 52-week high of $13.44, which the company reached on May 16th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 7.59% to $153.25, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 3.16% to $24.54.
Trading volume (1.2 M) eclipsed its 50-day average volume of 740,379.
Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 01, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。